Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening
Developing a Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening Among Rural Screening Age-Eligible Adults
3 other identifiers
interventional
30
1 country
1
Brief Summary
This study will garner preliminary data to develop a young adult-mediated intervention whereby a younger family member encourages their older family member to get colorectal cancer (CRC) screening. In Aim 1, survey data from n=150 younger (25-44 years old) and n=150 older (45-75 years old) adults living in rural communities will be collected. In Aim 2, intervention components will be evaluated using n=9 focus groups. The novel intervention will be assessed via a pilot trial (n=15 adult child/parent dyads) in Aim 3.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2023
CompletedFirst Posted
Study publicly available on registry
July 10, 2023
CompletedStudy Start
First participant enrolled
July 31, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
Study Completion
Last participant's last visit for all outcomes
December 31, 2027
April 15, 2026
April 1, 2026
1.4 years
June 23, 2023
April 14, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
CRC screening knowledge and awareness
A composite index score on four awareness items and 14 knowledge items adopted from prior research
2-months post-intervention
CRC screeningintentions
A single item, based on previous CRC screening research
2-months post-intervention
Study Arms (1)
Aim 3: Single arm, open-label, pre-test/post-test design pilot trial
OTHERSingle arm, open-label, pre-test/post-test design pilot trial
Interventions
Using a single arm, open-label, pre-test post-test design (n=15 adult child/parent dyads), assess the impact of a young adult-mediated intervention to increase CRC screening among a paired age-eligible family member (e.g., parent/grandparent). The focus of the intervention will be on changes in CRC screening awareness and intentions among the age-eligible adult, but we hypothesize that the young adult could benefit as well. Thus, in addition to assessing feasibility and acceptability, we will assess changes in 1) CRC screening intentions among the age-eligible adults and 2) CRC health literacy and awareness of screening guidelines among the younger adult participant.
Eligibility Criteria
You may qualify if:
- Residents of counties in the Virginia/North Carolina CRC hotspot
- years old
- Able to speak, write, and comprehend English
- Younger adult participants in Aims 3 must have an older, screening age-eligible relative with whom they speak with regularly (i.e., ≥ once every two weeks)
You may not qualify if:
- Participants in Aims 1 or 2 will be ineligible for Aim 3
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Virginia Commonwealth Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Virginia Commonwealth University
Richmond, Virginia, 23289, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Carrie A Miller, PhD, MPH
Virginia Commonwealth University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2023
First Posted
July 10, 2023
Study Start (Estimated)
July 31, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
April 15, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
There are no plans to share individual patient data.